The methylation of the MLH3 promoter, the deletion of the NGR3 and NBN genes or chromothripsis on 13q observed in our study are potential phenomena that might influence tumor cell behavior and thus modulate the tumor’s responsiveness to treatment. This evidence concerns the gene NBN and neoplasm.